Search | Feedback | Contents | Deutsch
 
 
Organ of the
 

 GD — Society for Dermopharmacy

   
 
Home
Issue 2/2006
Issue 1/2006
Issue 2/2005
Issue 1/2005
Issue 1/2004
Issue 2/2003
Issue 1/2003
Issue 2/2002
Issue 1/2002
Issue 4/2001
Issue 3/2001
Issue 2/2001
Issue 1/2001
Issue 1/2000
Newsletter
 
 
More Links:
 
 
Society for
Dermopharmacy
 
 
 
 
  Contents of all Issues

Authors' Articles
Book Reviews

Campany Protrait
Conference Report

Dermatica News
Dermatotherapy
Dermocosmetics
Dermopharmacy-News
Dermopharmacy today
Editorial
Events
Extemporaneous Preparations
GD Internal
GD News
Interviews
Position Papers of the GD



Authors' Articles

Year Issue Title
2005 1/2005 R. Eifler-Bollen, H. Reimann:Survey — Transparency for dermatic bases
2005 1/2005 A. Posselt, R. Daniels:Realistic expectations to UVA-protection by sun protection agents with high or very high sun protection factor
2004 1/2004 A. Posselt, R. Daniels: UVA-Protective Performance of Sun Protection Products — Has there been a market shift?
2003 1/2003 Horst Spielmann: New Methods for Animal-Experiment-Free Tolerability Tests of Cosmetics
2003 1/2003 Erik Senger: Dry Skin — From False Diagnosis to Treatment Concept
2003 1/2003 A. Schrader, S. Benard and M. Rohr: The Rationale and Practice of Biophotonics
2003 1/2003 Jean Krutmann: Targets for Repair-Products against Photoaging
2002 2/2002 Rolf Daniels: Novel Gel Systems
2002 1/2002 Th. Förster C. Jassoy, D. Petersohn, K. Schlotmann , M.Kaeten und M. Waldmann-Laue: Antiage-Bioactives in Cosmetic Products
2001 1/2001 Th. Förster, C. Jassoy, D. Petersohn, K. Schlotmann und M. Waldmann-Laue: Systematic Evaluation of new active Substances and Cosmetics

Book Reviews

Year Issue Title
2006 1/2006 Bernd Ziolkowsky (Ed.): Raw Material Encyclopaedia 2005/2006. Cosmetics Annual 2005
2006 1/2006 Ulrich Schwabe, Dieter Paffrath (Ed.): Arzneiverordnungs-Report 2005 (Drug Prescription Report), Current Data, Costs, Trends, and Comments
2005 1/2005 Christian Zeller: Globalization strategies - Novartis' road to success
2005 1/2005 Ulrich Schwabe, Dieter Paffrath (Ed.): Drug prescription report 2004. Current data, costs, trends and comments
2004 2/2004 M. Kerscher: Dermatocosmetics
2004 1/2004 U. Schwabe, D. Paffrath (Editors): Arzneiverordnungs-Report 2003 (Drug Prescription Report)
Current data, costs, trends and comments

Company Portrait

Year Issue Title
2005 2/2005 Intendis Dermatologie GmbH: New name, reliable partner
2005 2/2005 Rausch AG Kreuzlingen: Herbal competence for 115 years
2005 2/2005 Apotheker Walter Bouhon GmbH: Apothecary skin care products
2005 2/2005 Galderma Laboratorium GmbH: Major commitment in dermatology

Conference Report

Year Issue Title
2002 2/2002 6th Annual Meeting of the GD between 20 and 22 March 2002 in Hamburg: Wide-ranging Information and Interdisciplinary Knowledge Transfer
2001 1/2001 Congress Report: IFSCC 2000
2000 1/2000 4th Annual Meeting of the GD in Freiburg: A very special event

Dermatica News

Year Issue Title
2000 1/2000

Fluconazol: Long-term therapy for onychomycoses

2000 1/2000 Tacrolimus: Hope for atopical dermatitis

Dermatotherapy

Year Issue Title
2006 1/2006 GD-Symposium on Health Economy in Dermatology: Dermatological Therapy in Times of Health Reform
2006 1/2006 Dermatological Formulation in International Comparison: Increasing Efforts to Ensure Pharmaceutical Quality
2005 2/2005 Interdisciplinary progress for the benefit of skin: Trends in dermatotherapy
2005 1/2005 Treatment of sensitive and poorly curing wounds: Liposomal Povidone-iodine gel providing clinical and economical benefits
2005 1/2005 Topical therapy based on Pimecrolimus: Substantial arguments alluding to high effectiveness and safety
2004 2/2004 Guideline of the GD Gesellschaft für Dermopharmazie e. V. Version 1st April 2003:
Dermatological prescription
2004 2/2004 Imiquimod-Creme in use at non-melanocyte skin cancer: Refundable so far only therapy of the superficial basal cell carcinoma
2004 2/2004 Interview with Professor Dr. Thomas Luger on the Therapy of the Atopical Eczema Topical glucocorticoids are no longer the drug of first choice in either case
2003 2/2003 GKV-Modernisierungsgesetz (GMG) (GKV-Modernization Act): Consequences on prices and refundabilty of dermatics
2003 1/2003 Treatment of Mycosis Pedis by Means of Topical Antimycotics: The Basis is Likewise Important For a Successful Therapy
2002 1/2002 Transforming Growth Factor β (TGF-β): Dermatotherapeutics on the Horizon
2002 1/2002 Tinea Pedis Treatment: Advantages for topical Terbinafine
2002 1/2002 Economic effectiveness in topical Therapy: Drug price not the decisive Factor
2002 1/2002 Onychomycoses: New Therapy Option by Indication Extension for systemical Fluconazole
2001 3/2001 Medicinal Routine in all Departments: increasing Incidence of Mycoses
2001 3/2001 Positive List in decision-making Process: Specific Consequences still uncertain Current Dermopharmacy
2001 1/2001 Topical Terbinafin: High Compliance by Short Duration of Treatment — Professor Dr. med. Hans Christian Korting in Conversation with DermoTopics
2001 1/2001 New Approach for the Therapy of Onychomycoses: Laser Treatment in Combination with low-dose systemical Antimycotics
2001 1/2001 Exceptional Casuistics: Typ-I Allergy on a Systemical H1-Antihistamine Preparation
2001 1/2001 Sirolimus: Dermatotherapeutics on the Horizon

Dermocosmetics

Year Issue Title
2006 1/2006 Statement by GD - Gesellschaft für Dermopharmazie e.V.: UVA-Protective Performance of Sunscreens
2006 1/2006 15 Years of Service in Experimental Dermatology: Dermatological Research Institute at University Witten/Herdecke Celebrates Anniversary
2005 2/2005 Interdisciplinary progress for the benefit of skin: Advancements in the field of Dermocosmetics
2005 1/2005 Guideline of the Society for Dermopharmacy: Dermocosmetics for the Cleansing and Care of Skin Prone to Acne
2005 1/2005 Measures for the prevention from napkin dermatitis: Primary target is stabilization of the natural skin barrier
2004 1/2004 Dry skin low in Lipids: Vitally important – appropriate Skin Cleansing and Skin Care
2004 1/2004 Inflammatory and itching skin: Endocannabinoids as a new approach for anti-inflammatory effect
2002 2/2002 Novel Gel Systems: Multiple Applications in Dermocosmetics
2002 2/2002 Multi-functional Emulsion Systems: Not only Active Agent Carrier, but also Independent Cosmetic Active Principle´
2002 1/2002 Cosmetics and Skin Care from dermatological View: Current Trends in Dermocosmetics
2001 4/2001 GD-Symposium in Duesseldorf on 17 October 2001: Effects of Dermocosmetics
2001 2/2001 Sun Protection Preparations: High Protection Factors convey the misleadung Impression of Safety
2001 1/2001 Cream with Derma-Membrane Structure (DMS): New Approach for Care of Dry Skin

Dermopharmacy-News

Year Issue Title
2006 1/2006

Scientific Program of the 10th Annual Meeting of the Society for Dermopharmacy: 4th and 5th April 2006 in Münster

2006 1/2006 Occupational Skin Diseases: Swift Intervention by Dermatologists may Impede Loss of Job
2006 1/2006

Toxicological Safety Test: Skin Models Gaining Ground

2006 1/2006 GD-Symposium in Berlin on 17th November 2005: Benefit and Risks of Injectable Filling Materials for Skin Augmentation
2005 2/2005 Program of the GD-Symposium "Subcutaneous cosmetics and their alternatives: Benefit and risks of skin augmentation"
2005 1/2005 9th Annual Meeting of the Gesellschaft für Dermopharmazie in Vienna on 14 and 15 March: Diversified program at first GD-meeting in Austria
2004 2/2004 International Conference on Pharmaco-economics and Research of Quality of Life, Hamburg, October 2004: Cost-Benefit Analyses of Dermatics Increasingly Important
2004 2/2004 GD-Symposium in Berlin on 25 November 2004: Reduction of Animal Experiments by Human Skin Models
2004 1/2004 Crucial point in the therapy of mycoses pedis: Required compliance often not ensure
2004 1/2004 T-Lymphocyte-modulator Efalizumab: New therapy option at medium-severe to severe psoriasis
2004 1/2004 Symposium of DFG-Research Group 463 in Berlin: Targets, Drugs and Carriers. Novel Therapeutic Approaches
2004 1/2004 Health economy - main focus of GD-Symposium: Dermatology afflicted with GMG
2004 1/2004 8th annual meeting of the GD in Halle / Saale: Tradition and progress in Dermopharmacy
2003 2/2003 7th Annual Meeting of the Society for Dermopharmacy in Bonn on 1st and 2nd April 2003
Innovative Approach for the Treatment and Prevention of Skin Diseases
2002 2/2002 3rd Symposium “Health Economy in Dermatology”: Pharmaco-economy, Quality of Life and Quality Management in Clinic and Practice
2002 2/2002 6th Annual Meeting of the GD between 20 and 22 March 2002 in Hamburg: Wide-ranging Information and Interdisciplinary Knowledge Transfer
2002 1/2002 Workshop Conversation with Professor Dr. Rolf Daniels: Surfactant-free Emulsion Systems as Bases for innovative Dermatics and Cosmetics
2001 2/2001 Computer-aided Tele- and Dermatoscopy: High Level of Safety in Diagnosis of melanocyte Skin Changes
2001 2/2001 GD's 5th Annual Meeting in Zurich: Society for Dermopharmacy in Conference in the Swiss Metropolis

Dermopharmacy today

Year Issue Title
2000 1/2000 Pharmaco-economy: Significance for the dermatology

Editorial

Year Issue Title
2000 1/2000 Follow Me

Events

Year Issue Title
2002 2/2002 3rd Symposium “Health Economy in Dermatology”: Pharmaco-economy, Quality of Life and Quality Management in Clinic and Practice
2001 4/2001 GD-Symposium in Düsseldorf on 17 October 2001: Effects of Dermocosmetics

Extemporaneous Preparations

Year Issue Title
2001 4/2001 GD-Department Extemporaneous Preparations: Interdisciplinary Cooperation is the Patent Solution
2001 1/2001 Risks for Physicians and Pharmacists: Prescriptions at the Limits of the Freedom
2001 1/2001 Dermatologists and Pharmacists in Discussion: Cooperation for Solving of Prescription Problems

GD Internal

Year Issue Title
2000 1/2000 Department Dermatotherapy: Working priorities of interdisciplinary significance

GD News

Year Issue Title
2006 1/2006 Light Skin Cancer: GD Public Relations Successful
2006 1/2006 GD Press Campaign Relating to Sun Protection: UVA-Protection by Sunscreens – a Book of Seven Seals?
2006 1/2006 Risk Assessment and Regulatory Affairs New GD Department Set to Work with Ambitious Projects
2006 1/2006 10th Annual Meeting of the Gesellschaft für Dermopharmazie in Münster on 4th und 5th April 2006: Meeting Presents Numerous Novelties of Interdisciplinary Significance
2005 2/2005 Ten years' GD: First interdisciplinary football comparison between dermatologists and pharmacists: Pill kickers North-Rhine winning 3:1 versus the German dermatological national team
2005 2/2005 Ten years' GD: Ten years' GD – ten years of humaneness
2005 2/2005 Ten years' GD: Success through quality, competence and interdisciplinarity: Society for Dermopharmacy - ten years of successful work
2005 1/2005 GD press release concerning the consequences of the Health Care Reform: Drastical additional expenditures for patients suffering from chronical skin diseases
2005 1/2005 Award for successful development of test methods for reduction of animal experiments: Professor Dr. med. Horst Spielmann, Berlin, awarded with DIP 2005
2005 1/2005 Commitment for quality assurance: GD issues two further new guidelines focusing on dermopharmaceutical topics
2005 1/2005 Extension of present scope of activity: New GD department will be engaged in regulatory questions
2005 1/2005 Society for Dermopharmacy celebrates tenth birthday: Ten years of interdisciplinary progress for the well-being of skin
2004 2/2004 9th Annual Meeting of the GD in Vienna on 14th and 15th March 2005: GD organizes for the first time event in Austria
2004 2/2004 GD-guideline „Dermatological Prescriptions“ updated: Topical dermatological prescriptions – a quality feature of dermatologists and pharmacists
2004 2/2004 GD develops concept for interdisciplinary management of Tinea pedis: Mycoses pedis soon under control?
2004 1/2004 Award for merits in the field of occupational skin protection: Krefeld Skin Protection Prize conferred on GD-member professor Dr. med. Thomas L. Diepgen
2004 1/2004 GD press release for the prevention of skin cancer: Every year 100.000 new cases of basalioma, spinalioma and melanoma are reported
2004 1/2004 General meeting of the GD in Schkopau on 30 March 2004: Two new members in the management of an active scientific society
2003 2/2003 GD Homepage Established as Internet Portal for Dermopharmacy
2003 2/2003 Comprehensive Offer of Information for Experts, Media Representatives and Consumers
2003 2/2003 UV-related skin Damage and Repair Analyzed: Professor Dr. med. Jean Krutmann Awarded for his Practically-oriented Research in the Field of Photobiology of Skin
2003 1/2003 New Insights Regarding Light Skin Carcinoma: Society for Dermopharmacy establishes Task Force "Light.Skin Carcinoma.Prevention"
2003 1/2003 Definition by the Society for Dermopharmacy: What is the Meaning of the Term "Emulsifier-free"?
2003 1/2003 Statement of the Society for Dermopharmacy: Entry of Combined Topical Dermatics In Positive List
2002 2/2002 GD Statement: Duration of Therapy for Topical Treatment of Mycosis PedisS
2002 1/2002 Onychomycosis: GD publishes Information Brochure for Patients
2002 1/2002 Events offered by the GD: Seminars combined with practical Exercises
2002 1/2002 GD-Statement: Aut-idem-Regulation with Dermatological Preparations
2001 4/2001 Replacing of Laboratory Animals by Cell Experiments: OECD recommends Cell Experiments for the Test of new Drugs, Chemicals and cosmetical active Substances
2001 4/2001 New Methods of animal-experiment-free Cosmetics Examination: No Restriction of Consumer Protection
2001 4/2001 GD Statement: Dermocosmetics — Definition and Requirements
2001 4/2001 GD Statement: Potential of Occlusion by liquid Paraffin in Cosmetics
2001 4/2001 GD Statement: Potential of a Penetration Enhancement by Polyethylenglycol (PEG)-Compounds in Cosmetics
2001 3/2001 Scientific Program of the 6th Annual Meeting of the GD
2001 3/2001 3rd Symposium "Health Economics in Dermatology" - the Gesellschaft für Dermopharmazie now also deals with pharmaco-economic Questions
2001 3/2001 6th Annual Meeting of the GD between 20 and 22 March 2002 in Hamburg: Information Opportunities from all Sectors of Dermopharmacy
2001 3/2001 In artificially cultivated Full-thickness Models: Active Substances against Skin Ageing in cosmetic Preparations
2001 3/2001 New trends in Dermocosmetics: Approach for the Retarding of Skin Ageing
2001 3/2001 Gesellschaft für Dermopharmazie publishes Information Brochure for Consumers: Appropriate Cleansing and Care of dry Skin
2001 2/2001 GD-Symposium on 17 October in Duesseldorf: Effects of Dermocosmetics
2001 2/2001 Proof of trust for additional three Years: General Meeting confirms GD-Board
2001 2/2001 GD Homepage: Development of Dermopharmacy Portal
2001 2/2001 Active Substance Dexpanthenol: Equally important — good Tolerability and Effectiveness
2001 2/2001 Every third person suffers from Athlete's Foot Disease: Appropiate Treatment instead of playing down the Disease

Interviews

Year Issue Title
2003 1/2003 Treatment of Mycosis Pedis by Means of Topical Antimycotics: The Basis is Likewise Important For a Successful Therapy
2001 4/2001 Interview with Dr. Thomas Förster: Effects on Dermocosmetics
2001 1/2001 Topical Terbinafin: High Compliance by Short Duration of Treatment — Professor Dr. med. Hans Christian Korting in Conversation with DermoTopics
2000 1/2000 Professor Dr. med. Max Gloor in Conversation with DermoTopics: Extemporaneous Preparations — A domain of dermatologists in discussion

Position Papers of the GD

Year Issue Title
2001 1/2001 GD adopts additional Guidelines: Dermocosmetics for the Cleansing of dry Skin
2001 1/2001 GD-Statement: Skin Cleansing of dry Skin - a problem?
2001 1/2001 GD Statement: Prescriptions for aesthetic Applications


top

February 2008 Copyright © 2000 - 2014 Institute for Dermopharmacy GmbH. Contact: webmaster@gd-online.de